vs
Idexx Laboratories（IDXX）与罗克韦尔自动化（ROK）财务数据对比。点击上方公司名可切换其他公司
罗克韦尔自动化的季度营收约是Idexx Laboratories的1.9倍（$2.1B vs $1.1B），Idexx Laboratories净利率更高（22.8% vs 14.5%，领先8.3%），Idexx Laboratories同比增速更快（14.3% vs 11.9%），Idexx Laboratories自由现金流更多（$326.3M vs $170.0M），过去两年Idexx Laboratories的营收复合增速更高（6.4% vs -0.5%）
IDEXX Laboratories是1983年成立的美国跨国企业，主营伴侣动物诊疗、畜禽养殖、水质检测、乳制品领域相关产品与服务的研发、生产及分销，总部位于缅因州韦斯特布鲁克，欧洲、中东及非洲地区分部设于荷兰霍夫多普。
罗克韦尔自动化是总部位于美国威斯康星州密尔沃基的工业自动化及数字化转型技术提供商，旗下拥有Allen-Bradley、FactoryTalk软件、LifecycleIQ服务等核心品牌，全球员工约2.7万人，服务覆盖100多个国家和地区的客户。
IDXX vs ROK — 直观对比
营收规模更大
ROK
是对方的1.9倍
$1.1B
营收增速更快
IDXX
高出2.4%
11.9%
净利率更高
IDXX
高出8.3%
14.5%
自由现金流更多
IDXX
多$156.3M
$170.0M
两年增速更快
IDXX
近两年复合增速
-0.5%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $1.1B | $2.1B |
| 净利润 | $248.2M | $305.0M |
| 毛利率 | 60.3% | 48.3% |
| 营业利润率 | 28.9% | 20.7% |
| 净利率 | 22.8% | 14.5% |
| 营收同比 | 14.3% | 11.9% |
| 净利润同比 | 14.8% | 65.8% |
| 每股收益（稀释后） | $3.09 | $2.69 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收IDXXROK
| Q4 25 | $1.1B | $2.1B | ||
| Q3 25 | $1.1B | $2.3B | ||
| Q2 25 | $1.1B | $2.1B | ||
| Q1 25 | $998.4M | $2.0B | ||
| Q4 24 | $954.3M | $1.9B | ||
| Q3 24 | $975.5M | $2.0B | ||
| Q2 24 | $1.0B | $2.1B | ||
| Q1 24 | $964.1M | $2.1B |
净利润IDXXROK
| Q4 25 | $248.2M | $305.0M | ||
| Q3 25 | $274.6M | $138.0M | ||
| Q2 25 | $294.0M | $295.0M | ||
| Q1 25 | $242.7M | $252.0M | ||
| Q4 24 | $216.1M | $184.0M | ||
| Q3 24 | $232.8M | $239.1M | ||
| Q2 24 | $203.3M | $232.0M | ||
| Q1 24 | $235.6M | $266.2M |
毛利率IDXXROK
| Q4 25 | 60.3% | 48.3% | ||
| Q3 25 | 61.8% | 69.4% | ||
| Q2 25 | 62.6% | 40.9% | ||
| Q1 25 | 62.4% | 40.5% | ||
| Q4 24 | 59.8% | 38.4% | ||
| Q3 24 | 61.1% | 37.9% | ||
| Q2 24 | 61.7% | 38.8% | ||
| Q1 24 | 61.5% | 39.2% |
营业利润率IDXXROK
| Q4 25 | 28.9% | 20.7% | ||
| Q3 25 | 32.1% | 2.7% | ||
| Q2 25 | 33.6% | 16.0% | ||
| Q1 25 | 31.7% | 14.9% | ||
| Q4 24 | 27.4% | 17.1% | ||
| Q3 24 | 31.2% | 13.5% | ||
| Q2 24 | 26.3% | 12.4% | ||
| Q1 24 | 31.0% | 14.6% |
净利率IDXXROK
| Q4 25 | 22.8% | 14.5% | ||
| Q3 25 | 24.8% | 6.0% | ||
| Q2 25 | 26.5% | 13.8% | ||
| Q1 25 | 24.3% | 12.6% | ||
| Q4 24 | 22.7% | 9.8% | ||
| Q3 24 | 23.9% | 11.7% | ||
| Q2 24 | 20.3% | 11.3% | ||
| Q1 24 | 24.4% | 12.5% |
每股收益（稀释后）IDXXROK
| Q4 25 | $3.09 | $2.69 | ||
| Q3 25 | $3.40 | $1.24 | ||
| Q2 25 | $3.63 | $2.60 | ||
| Q1 25 | $2.96 | $2.22 | ||
| Q4 24 | $2.62 | $1.61 | ||
| Q3 24 | $2.80 | $2.09 | ||
| Q2 24 | $2.44 | $2.02 | ||
| Q1 24 | $2.81 | $2.31 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $180.1M | $444.0M |
| 总债务越低越好 | $450.0M | — |
| 股东权益账面价值 | $1.6B | $3.7B |
| 总资产 | $3.4B | $11.2B |
| 负债/权益比越低杠杆越低 | 0.28× | — |
8季度趋势，按日历期对齐
现金及短期投资IDXXROK
| Q4 25 | $180.1M | $444.0M | ||
| Q3 25 | $208.2M | $468.0M | ||
| Q2 25 | $164.6M | $495.0M | ||
| Q1 25 | $164.0M | $456.0M | ||
| Q4 24 | $288.3M | $477.0M | ||
| Q3 24 | $308.6M | $471.3M | ||
| Q2 24 | $401.6M | $407.0M | ||
| Q1 24 | $397.4M | $470.5M |
总债务IDXXROK
| Q4 25 | $450.0M | — | ||
| Q3 25 | — | $2.6B | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $617.8M | — | ||
| Q3 24 | — | $2.6B | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益IDXXROK
| Q4 25 | $1.6B | $3.7B | ||
| Q3 25 | $1.6B | $3.7B | ||
| Q2 25 | $1.5B | $3.5B | ||
| Q1 25 | $1.4B | $3.4B | ||
| Q4 24 | $1.6B | $3.4B | ||
| Q3 24 | $1.6B | $3.5B | ||
| Q2 24 | $1.6B | $3.3B | ||
| Q1 24 | $1.6B | $3.5B |
总资产IDXXROK
| Q4 25 | $3.4B | $11.2B | ||
| Q3 25 | $3.4B | $11.2B | ||
| Q2 25 | $3.3B | $11.2B | ||
| Q1 25 | $3.2B | $11.0B | ||
| Q4 24 | $3.3B | $10.9B | ||
| Q3 24 | $3.4B | $11.2B | ||
| Q2 24 | $3.4B | $11.2B | ||
| Q1 24 | $3.4B | $11.4B |
负债/权益比IDXXROK
| Q4 25 | 0.28× | — | ||
| Q3 25 | — | 0.72× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.39× | — | ||
| Q3 24 | — | 0.73× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $355.8M | $234.0M |
| 自由现金流经营现金流 - 资本支出 | $326.3M | $170.0M |
| 自由现金流率自由现金流/营收 | 29.9% | 8.1% |
| 资本支出强度资本支出/营收 | 2.7% | 3.0% |
| 现金转化率经营现金流/净利润 | 1.43× | 0.77× |
| 过去12个月自由现金流最近4个季度 | $1.1B | — |
8季度趋势，按日历期对齐
经营现金流IDXXROK
| Q4 25 | $355.8M | $234.0M | ||
| Q3 25 | $402.3M | $454.0M | ||
| Q2 25 | $185.7M | $527.0M | ||
| Q1 25 | $238.0M | $199.0M | ||
| Q4 24 | $262.0M | $364.0M | ||
| Q3 24 | $220.1M | $432.3M | ||
| Q2 24 | $248.3M | $279.1M | ||
| Q1 24 | $198.6M | $119.8M |
自由现金流IDXXROK
| Q4 25 | $326.3M | $170.0M | ||
| Q3 25 | $371.2M | — | ||
| Q2 25 | $151.6M | $489.0M | ||
| Q1 25 | $207.9M | $171.0M | ||
| Q4 24 | $232.8M | $293.0M | ||
| Q3 24 | $192.0M | — | ||
| Q2 24 | $215.0M | $238.4M | ||
| Q1 24 | $168.3M | $68.6M |
自由现金流率IDXXROK
| Q4 25 | 29.9% | 8.1% | ||
| Q3 25 | 33.6% | — | ||
| Q2 25 | 13.7% | 22.8% | ||
| Q1 25 | 20.8% | 8.5% | ||
| Q4 24 | 24.4% | 15.6% | ||
| Q3 24 | 19.7% | — | ||
| Q2 24 | 21.4% | 11.6% | ||
| Q1 24 | 17.5% | 3.2% |
资本支出强度IDXXROK
| Q4 25 | 2.7% | 3.0% | ||
| Q3 25 | 2.8% | — | ||
| Q2 25 | 3.1% | 1.8% | ||
| Q1 25 | 3.0% | 1.4% | ||
| Q4 24 | 3.1% | 3.8% | ||
| Q3 24 | 2.9% | — | ||
| Q2 24 | 3.3% | 2.0% | ||
| Q1 24 | 3.1% | 2.4% |
现金转化率IDXXROK
| Q4 25 | 1.43× | 0.77× | ||
| Q3 25 | 1.47× | 3.29× | ||
| Q2 25 | 0.63× | 1.79× | ||
| Q1 25 | 0.98× | 0.79× | ||
| Q4 24 | 1.21× | 1.98× | ||
| Q3 24 | 0.95× | 1.81× | ||
| Q2 24 | 1.22× | 1.20× | ||
| Q1 24 | 0.84× | 0.45× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
IDXX
| Vet Lab Consumables | $389.0M | 36% |
| Reference Laboratory Diagnostic And Consulting Services | $349.2M | 32% |
| Rapid Assay Products | $76.0M | 7% |
| Recurring Revenue | $70.6M | 6% |
| CAG Diagnostic Capital Instruments | $58.1M | 5% |
| Water Segment | $50.5M | 5% |
| Livestock And Poultry Diagnostics Segment | $37.5M | 3% |
| CAG Diagnostics Service And Accessories | $35.3M | 3% |
| Systems And Hardware | $20.1M | 2% |
| Rebate And Up Front Considerations Arrangements | $2.4M | 0% |
| Extended Warranties And Post Contract Support Revenue | $1.0M | 0% |
ROK
| Productsand Solutions | $1.9B | 89% |
| Lifecycle Services Segment | $259.0M | 12% |
